ATE359561T1 - Rechnerverfahren freie energieberechnung für ligandenentwurf verwendend und die voraussage von bindenden zielen - Google Patents
Rechnerverfahren freie energieberechnung für ligandenentwurf verwendend und die voraussage von bindenden zielenInfo
- Publication number
- ATE359561T1 ATE359561T1 AT98925162T AT98925162T ATE359561T1 AT E359561 T1 ATE359561 T1 AT E359561T1 AT 98925162 T AT98925162 T AT 98925162T AT 98925162 T AT98925162 T AT 98925162T AT E359561 T1 ATE359561 T1 AT E359561T1
- Authority
- AT
- Austria
- Prior art keywords
- binding
- targets
- binding targets
- optimal
- protein
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
- G16B15/30—Drug targeting using structural data; Docking or binding prediction
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/30—Detection of binding sites or motifs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Theoretical Computer Science (AREA)
- Evolutionary Biology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Crystallography & Structural Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4827497P | 1997-06-02 | 1997-06-02 | |
US6649597P | 1997-11-25 | 1997-11-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE359561T1 true ATE359561T1 (de) | 2007-05-15 |
Family
ID=26725962
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98925162T ATE359561T1 (de) | 1997-06-02 | 1998-06-02 | Rechnerverfahren freie energieberechnung für ligandenentwurf verwendend und die voraussage von bindenden zielen |
Country Status (7)
Country | Link |
---|---|
US (3) | US6226603B1 (de) |
EP (1) | EP1025521B1 (de) |
AT (1) | ATE359561T1 (de) |
CA (1) | CA2292697C (de) |
DE (1) | DE69837555T2 (de) |
ES (1) | ES2285774T3 (de) |
WO (1) | WO1998054665A1 (de) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6027711A (en) * | 1995-06-07 | 2000-02-22 | Rhomed Incorporated | Structurally determined metallo-constructs and applications |
EP1228370A2 (de) * | 1999-11-10 | 2002-08-07 | Structural Bioinformatics Inc. | Computerableitbare proteinstrukturen in pharmakogenomik |
TW486653B (en) * | 2000-03-17 | 2002-05-11 | Hitachi Ltd | Chemical material integrated management system and method thereof |
WO2001071347A1 (en) * | 2000-03-23 | 2001-09-27 | California Institute Of Technology | Method and apparatus for predicting ligand binding interactions |
CA2346588A1 (en) * | 2000-05-08 | 2001-11-08 | Molecular Simulations Inc. | Methods and systems for estimating binding affinity |
WO2002023189A1 (en) * | 2000-09-12 | 2002-03-21 | Johns Hopkins University | Structural prediction of allosterism |
JPWO2002025274A1 (ja) * | 2000-09-20 | 2004-01-29 | 清野 祐子 | 反応検出方法、免疫反応検出方法及び装置 |
EP1209610A1 (de) * | 2000-11-28 | 2002-05-29 | Valentin Capital Management | Verfahren und Vorrichtung zur Bestimmung von Ligand/Ziel-Affinitätsdaten |
WO2002044990A2 (en) * | 2000-11-28 | 2002-06-06 | Valentin Capital Management | Apparatus and method for determining affinity data between a target and a ligand |
US20050014193A1 (en) * | 2003-06-17 | 2005-01-20 | Sharma Shubh D. | Identification of target-specific folding sites in peptides and proteins |
US7351690B2 (en) * | 2000-12-19 | 2008-04-01 | Palatin Technologies, Inc. | Knockout identification of target-specific sites in peptides |
WO2002054063A1 (en) * | 2001-01-04 | 2002-07-11 | Yeda Research And Development Co. Ltd. | Database system and method useful for predicting the effect of amino acid substitutions on protein structure and stability |
US20030032065A1 (en) * | 2001-03-12 | 2003-02-13 | Vince Hilser | Ensemble-based strategy for the design of protein pharmaceuticals |
WO2002073193A1 (en) * | 2001-03-12 | 2002-09-19 | Board Of Regents, The University Of Texas System | Computer-based strategy for peptide and protein conformational ensemble enumeration and ligand affinity analysis |
US7560424B2 (en) | 2001-04-30 | 2009-07-14 | Zystor Therapeutics, Inc. | Targeted therapeutic proteins |
US7629309B2 (en) * | 2002-05-29 | 2009-12-08 | Zystor Therapeutics, Inc. | Targeted therapeutic proteins |
ES2300439T3 (es) | 2001-04-30 | 2008-06-16 | Zystor Therapeutics , Inc. | Reconocimiento subcelular de proteinas terapeuticas. |
US20040005309A1 (en) * | 2002-05-29 | 2004-01-08 | Symbiontics, Inc. | Targeted therapeutic proteins |
EP1409982A4 (de) * | 2001-06-14 | 2006-05-24 | Anadys Pharmaceuticals Inc | Verfahren zum screening auf liganden von zielmolekülen |
US7107156B2 (en) * | 2001-07-23 | 2006-09-12 | Accelrys Software Inc. | Method and apparatus for estimating solvation energies of membrane bound molecules |
US20030072761A1 (en) * | 2001-10-16 | 2003-04-17 | Lebowitz Jonathan | Methods and compositions for targeting proteins across the blood brain barrier |
US20090182542A9 (en) * | 2001-12-22 | 2009-07-16 | Hilton Jeremy P | Hybrid classical-quantum computer architecture for molecular modeling |
US6671628B2 (en) * | 2002-03-04 | 2003-12-30 | Chemnavigator, Inc. | Methods for identifying a molecule that may bind to a target molecule |
US20030216867A1 (en) * | 2002-03-26 | 2003-11-20 | Campbell Phil G. | Methods and systems for molecular modeling |
WO2003095494A1 (en) | 2002-05-10 | 2003-11-20 | Bio-Layer Pty Limited | Generation of surface coating diversity |
CA2487006A1 (en) * | 2002-05-23 | 2003-12-04 | Vince Hilser | Predicting the significance of single nucleotide polymorphisms (snps) using ensemble-based structural energetics |
DE60312330T2 (de) * | 2002-06-10 | 2007-11-22 | Algonomics N.V. | Verfahren zur vorhersage der bindungsaffinität der mhc-peptid-komplexe |
US20040034481A1 (en) * | 2002-08-16 | 2004-02-19 | Hurst John R. | Methods for identifying a prospective binding site on a target molecule and for characterizing a site on a target molecule |
US7660677B2 (en) * | 2002-09-03 | 2010-02-09 | Sei-ichi Tanuma | Method of designing physiologically active peptide and use thereof |
EP1610825A2 (de) * | 2003-03-31 | 2006-01-04 | Xencor, Inc. | Verfahren zur rationellen pegylierung von proteinen |
US7610156B2 (en) | 2003-03-31 | 2009-10-27 | Xencor, Inc. | Methods for rational pegylation of proteins |
US7642340B2 (en) | 2003-03-31 | 2010-01-05 | Xencor, Inc. | PEGylated TNF-α variant proteins |
WO2005057462A1 (en) * | 2003-12-12 | 2005-06-23 | Bio-Layer Pty Limited | A method for designing surfaces |
DE602005020745D1 (de) * | 2004-02-10 | 2010-06-02 | Zystor Therapeutics Inc | Saure alpha-glukosidase und fragmente davon |
US20070239366A1 (en) * | 2004-06-05 | 2007-10-11 | Hilton Jeremy P | Hybrid classical-quantum computer architecture for molecular modeling |
US8168445B2 (en) | 2004-07-02 | 2012-05-01 | Bio-Layer Pty Limited | Use of metal complexes |
US20060052943A1 (en) * | 2004-07-28 | 2006-03-09 | Karthik Ramani | Architectures, queries, data stores, and interfaces for proteins and drug molecules |
US8117902B2 (en) * | 2005-11-03 | 2012-02-21 | University Of Massachusetts | Nanopatterned surfaces and related methods for selective adhesion, sensing and separation |
US20090306342A1 (en) * | 2005-12-30 | 2009-12-10 | Bio-Layer Pty Limited | Binding of molecules |
EP2004678A1 (de) * | 2006-03-15 | 2008-12-24 | Csir | Modulation der glutaminsynthetaseaktivität |
EP1916516A1 (de) | 2006-10-27 | 2008-04-30 | Bayer CropScience AG | Methode für die Ermittlung der Intra- und intermolekularen Interaktionen in einer wässrigen Lösung |
EP2099523A2 (de) * | 2006-11-13 | 2009-09-16 | ZyStor Therapeutics , Inc. | Verfahren zur behandlung von pompe-krankheit |
US20090006059A1 (en) * | 2007-06-27 | 2009-01-01 | Nidhi Arora | Systems and methods for mapping binding site volumes in macromolecules |
US7756674B2 (en) * | 2007-08-03 | 2010-07-13 | The Trustees Of Columbia University In The City Of New York | Methods of calculating differences of binding affinities between congeneric pairs of ligands by way of a displaced solvent functional |
US8374828B1 (en) | 2007-12-24 | 2013-02-12 | The University Of North Carolina At Charlotte | Computer implemented system for protein and drug target design utilizing quantified stability and flexibility relationships to control function |
US8244504B1 (en) | 2007-12-24 | 2012-08-14 | The University Of North Carolina At Charlotte | Computer implemented system for quantifying stability and flexibility relationships in macromolecules |
ES2830350T3 (es) | 2008-05-07 | 2021-06-03 | Biomarin Pharm Inc | Péptidos de dirección lisosómica y usos de los mismos |
ES2569514T3 (es) | 2009-06-17 | 2016-05-11 | Biomarin Pharmaceutical Inc. | Formulaciones para enzimas lisosómicas |
EA025399B1 (ru) | 2010-11-22 | 2016-12-30 | Борис Славинович ФАРБЕР | Способ синтеза лечебных и профилактических лекарственных препаратов |
WO2013097012A1 (pt) * | 2011-12-30 | 2013-07-04 | Embrapa - Empresa Brasileira De Pesquisa Agropecuária | Inibidores das enzimas poligalacturonases de fungos fitopatogênicos |
US20130280238A1 (en) * | 2012-04-24 | 2013-10-24 | Laboratory Corporation Of America Holdings | Methods and Systems for Identification of a Protein Binding Site |
CN103870644B (zh) * | 2014-03-11 | 2016-08-03 | 中国石油大学(华东) | 一种识别MoP催化剂脱氮活性位的方法 |
JP6845157B2 (ja) | 2015-05-01 | 2021-03-17 | シュレーディンガー エルエルシーSchrodinger,Llc | 化合物の溶解度を予測するための物理学をベースにした計算方法 |
EP3374906B1 (de) * | 2015-11-09 | 2022-01-05 | The University Of British Columbia | Systeme und verfahren zur vorhersage missgefalteter proteinepitope durch kollektives koordinatenbiasing |
US11728011B2 (en) | 2019-04-29 | 2023-08-15 | International Business Machines Corporation | System and method for molecular design on a quantum computer |
IT201900022545A1 (it) | 2019-11-29 | 2021-05-29 | Univ Degli Studi Di Bari Aldo Moro | Metodo per l’identificazione di regioni di legame specifiche di deidrogenasi fad/nadh-dipendenti di mammiferi e/o di microorganismi patogeni per uomo, altri mammiferi e piante, per il disegno di nuovi farmaci |
WO2023172635A1 (en) * | 2022-03-08 | 2023-09-14 | Emory University | Predictive model for variants associated with drug resistance and theranostic applications thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5331573A (en) * | 1990-12-14 | 1994-07-19 | Balaji Vitukudi N | Method of design of compounds that mimic conformational features of selected peptides |
US5642292A (en) * | 1992-03-27 | 1997-06-24 | Akiko Itai | Methods for searching stable docking models of biopolymer-ligand molecule complex |
US5434796A (en) * | 1993-06-30 | 1995-07-18 | Daylight Chemical Information Systems, Inc. | Method and apparatus for designing molecules with desired properties by evolving successive populations |
US5495423A (en) * | 1993-10-25 | 1996-02-27 | Trustees Of Boston University | General strategy for vaccine and drug design |
US5867402A (en) * | 1995-06-23 | 1999-02-02 | The United States Of America As Represented By The Department Of Health And Human Services | Computational analysis of nucleic acid information defines binding sites |
US5854992A (en) * | 1996-09-26 | 1998-12-29 | President And Fellows Of Harvard College | System and method for structure-based drug design that includes accurate prediction of binding free energy |
-
1998
- 1998-06-02 DE DE69837555T patent/DE69837555T2/de not_active Expired - Fee Related
- 1998-06-02 AT AT98925162T patent/ATE359561T1/de not_active IP Right Cessation
- 1998-06-02 WO PCT/US1998/011261 patent/WO1998054665A1/en active IP Right Grant
- 1998-06-02 US US09/089,097 patent/US6226603B1/en not_active Expired - Fee Related
- 1998-06-02 EP EP98925162A patent/EP1025521B1/de not_active Expired - Lifetime
- 1998-06-02 ES ES98925162T patent/ES2285774T3/es not_active Expired - Lifetime
- 1998-06-02 CA CA002292697A patent/CA2292697C/en not_active Expired - Fee Related
-
2000
- 2000-12-13 US US09/734,696 patent/US6772073B2/en not_active Expired - Fee Related
-
2004
- 2004-05-21 US US10/849,941 patent/US20050010368A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1998054665A1 (en) | 1998-12-03 |
EP1025521B1 (de) | 2007-04-11 |
DE69837555T2 (de) | 2007-12-20 |
US6772073B2 (en) | 2004-08-03 |
CA2292697A1 (en) | 1998-12-03 |
ES2285774T3 (es) | 2007-11-16 |
US6226603B1 (en) | 2001-05-01 |
CA2292697C (en) | 2006-08-08 |
EP1025521A4 (de) | 2000-11-29 |
DE69837555D1 (de) | 2007-05-24 |
EP1025521A1 (de) | 2000-08-09 |
US20050010368A1 (en) | 2005-01-13 |
US20010000807A1 (en) | 2001-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE359561T1 (de) | Rechnerverfahren freie energieberechnung für ligandenentwurf verwendend und die voraussage von bindenden zielen | |
Kritzer et al. | β-Peptides as inhibitors of protein–protein interactions | |
Mei et al. | A new set of amino acid descriptors and its application in peptide QSARs | |
Paterova et al. | Reversal of the Hofmeister series: specific ion effects on peptides | |
Qiu et al. | The GB/SA continuum model for solvation. A fast analytical method for the calculation of approximate Born radii | |
Dive et al. | RXP 407, a phosphinic peptide, is a potent inhibitor of angiotensin I converting enzyme able to differentiate between its two active sites | |
Malleshappa Gowder et al. | Prediction and analysis of surface hydrophobic residues in tertiary structure of proteins | |
Dudev et al. | Factors governing the protonation state of cysteines in proteins: An ab initio/CDM study | |
Weintraub | Release of discrete subunits after nuclease and trypsin digestion of chromatin. | |
Friedrich et al. | From complex natural products to simple synthetic mimetics by computational de novo design | |
CN109036580B (zh) | 基于相互作用能项和机器学习的蛋白-配体亲和力预测方法 | |
Joughin et al. | A computational method for the analysis and prediction of protein: phosphopeptide‐binding sites | |
Eisenhaber et al. | Hydrophobic regions on protein surfaces: definition based on hydration shell structure and a quick method for their computation | |
Washburn | Utilisation of proteomics datasets generated via multidimensional protein identification technology (MudPIT) | |
Spicer et al. | N-capping motifs promote interaction of amphipathic helical peptides with hydrophobic surfaces and drastically alter hydrophobicity values of individual amino acids | |
Chen et al. | Rational design of YAP WW1 domain‐binding peptides to target TGFβ/BMP/Smad–YAP interaction in heterotopic ossification | |
Grant | Nonuniform charge effects in protein− protein interactions | |
Blindauer et al. | Inert site in a protein zinc cluster: Isotope exchange by high resolution mass spectrometry | |
Kroiss et al. | Unbiased discovery of dynamic peptide‐ATP complexes | |
Jing et al. | Rational design of angiotensin‐I‐converting enzyme inhibitory peptides by integrating in silico modeling and an in vitro assay | |
Tajimi et al. | Computational prediction of plasma protein binding of cyclic peptides from small molecule experimental data using sparse modeling techniques | |
Caron et al. | Proteomic map and database of lymphoblastoid proteins | |
Böcker et al. | Structure and Dynamics at the Liquid Mercury− Water Interface | |
Wilkins et al. | Selective enrichment of low-abundance peptides in complex mixtures by elution-modified displacement chromatography and their identification by electrospray ionization mass spectrometry | |
Loeffler et al. | Kinetic barriers in the isomerization of substituted ureas: implications for computer-aided drug design |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |